{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-278392","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.320948+00:00","generated_at":"2026-05-16T20:14:15.811559+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Eledon raises ~$46.5M in public offering of common stock and pre-funded warrants","bullets":["Underwritten offering of 15.15M shares at $1.65/share and up to 15.15M pre-funded warrants at $1.649/warrant.","Net proceeds estimated at $46.5M; up to $53.6M if underwriters' 30-day option is fully exercised.","Proceeds to fund clinical development of product candidates and for general corporate purposes.","Underwriters granted 30-day option to purchase up to 4.55M additional shares of common stock.","Company and certain insiders subject to 60-day lock-up on sales of securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-278392","json":"https://secwatch.observer/filing/0001193125-25-278392.json","markdown":"https://secwatch.observer/filing/0001193125-25-278392.md","text":"https://secwatch.observer/filing/0001193125-25-278392.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000119312525278392/0001193125-25-278392-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000119312525278392/d28785d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:14:15.811559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}